Perceptive Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-178,797
| Closed | -$9.13M | – | 113 |
|
2024
Q4 | $9.13M | Buy |
+178,797
| New | +$9.13M | 0.25% | 64 |
|
2022
Q4 | – | Sell |
-70,000
| Closed | -$5.09M | – | 111 |
|
2022
Q3 | $5.09M | Buy |
+70,000
| New | +$5.09M | 0.15% | 80 |
|
2022
Q2 | – | Sell |
-30,000
| Closed | -$2.72M | – | 129 |
|
2022
Q1 | $2.72M | Buy |
+30,000
| New | +$2.72M | 0.05% | 113 |
|
2021
Q3 | – | Sell |
-310,437
| Closed | -$29M | – | 157 |
|
2021
Q2 | $29M | Sell |
310,437
-254,676
| -45% | -$23.8M | 0.38% | 61 |
|
2021
Q1 | $60.5M | Sell |
565,113
-103,387
| -15% | -$11.1M | 0.76% | 34 |
|
2020
Q4 | $58.4M | Sell |
668,500
-180,000
| -21% | -$15.7M | 0.63% | 40 |
|
2020
Q3 | $58.6M | Buy |
848,500
+152,500
| +22% | +$10.5M | 0.86% | 32 |
|
2020
Q2 | $33.7M | Buy |
+696,000
| New | +$33.7M | 0.55% | 45 |
|